Renaissance Technologies - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 26 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q1 2016$257,000
-13.8%
950,900
+22.1%
0.00%
-100.0%
Q4 2015$298,000
+38.6%
778,800
+34.3%
0.00%0.0%
Q3 2015$215,000
-13.3%
580,000
+14.4%
0.00%0.0%
Q2 2015$248,000
+1553.3%
507,000
+2291.5%
0.00%
Q1 2015$15,00021,2000.00%
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q4 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,252,964$6,804,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 175,815$531,0000.13%
THOMPSON DAVIS & CO., INC. 0$9,0000.01%
Spark Investment Management LLC 11,200$33,0000.01%
Virtu KCG Holdings LLC 55,599$167,0000.00%
Ground Swell Capital, LLC 302$1,0000.00%
JANE STREET GROUP, LLC 62,219$188,0000.00%
Tower Research Capital LLC (TRC) 1,668$5,0000.00%
DIMENSIONAL FUND ADVISORS LP 61$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 11$33,0000.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders